RxDoctor Payments Data

Toni Hickey

Psychiatric/Mental Health · Pinellas Park, FLNPI 1598481822

Payments from drug & device makers

$4,152in general payments, 2019–2025

Across 169 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$890
  • Alkermes, Inc.$762
  • Otsuka America Pharmaceutical, Inc.$559
  • Johnson & Johnson$476
  • Teva Pharmaceuticals USA, Inc.$424
  • Idorsia Pharmaceuticals US Inc$280
  • plus $762 from 8 others

What the payments were for

  • Food & beverage$4,08698%
  • Education$662%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,152 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate24$187,625
LybalviOlanzapine/Samidorphan Malate64$104,811
VraylarCariprazine Hcl43$65,694
RexultiBrexpiprazole16$23,834
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl124$15,305
BelsomraSuvorexant24$11,706
Olanzapine289$9,498
QuviviqDaridorexant Hcl16$7,791
FetzimaLevomilnacipran Hcl12$6,339
DayvigoLemborexant15$5,182
Aripiprazole123$4,319
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine67$3,112
Gabapentin244$2,555
Quetiapine Fumarate234$2,255
Buprenorphine Hcl28$2,176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$250$187,62524 claims
Alkermes, Inc.Lybalvi$762$104,81164 claims
AbbVieVraylar, Fetzima$890$72,03455 claims
Otsuka America Pharmaceutical, Inc.Rexulti$559$23,83416 claims
Idorsia Pharmaceuticals US IncQuviviq$280$7,79116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Pinellas Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →